Document ID: chunk:federal_register_of_legislation:F2025L00049:schedule:6:p29
Version: federal_register_of_legislation:F2025L00049
Segment Type: schedule
Provision Reference: sch 6 (pt 29/36)
Character Range: 392222–395406

a nominal capacity of 15 mL or less fitted with a restricted flow insert and a child‑resistant closure and compliant with the requirements of the required advisory statements for medicine labels; or

       (b) in preparations other than medicines for human therapeutic use, when packed in containers having a nominal capacity of 15 mL or less fitted with a restricted flow insert and a child‑resistant closure and labelled with the warnings:

          (i) KEEP OUT OF REACH OF CHILDREN; and

          (ii) NOT TO BE TAKEN; or

       (c) in preparations containing 4% or less of d‑pulegone.
    PENTACHLOROPHENOL in preparations containing 1.5% or less of pentachlorophenol.
    PERACETIC ACID except when included in Schedule 5.
    PERFLUIDONE.
    PERMANGANATES except potassium permanganate in aqueous solutions containing 1% or less of potassium permanganate.
    PERMETHRIN except:

       (a) when included in Schedule 4 or 5; or

       (b) in preparations for human therapeutic use containing 5% or less of permethrin; or

       (c) in preparations containing 2% or less of permethrin.
    2‑PHENOXYETHANOL except:

       (a) in cosmetic preparations containing 1% or less of 2‑phenoxyethanol; or

       (b) in other preparations containing 15% or less of 2‑phenoxyethanol.
    PHENOL, including cresols and xylenols and any other homologue of phenol boiling below 220°C, except:

       (a) when separately specified in these Schedules; or

       (b) in preparations containing 1% or less of phenols, and in preparations containing 3% or less of cresols and xylenols and other homologues of phenol.
    PHENOTHIAZINE (excluding its derivatives) except in preparations containing 10% or less of phenothiazine.
    PHENOXYMETHYL OXIRANE.
    PHENYLENEDIAMINES including alkylated, arylated, halogenated and nitro derivatives not elsewhere specified in these Schedules:

       (a) in preparations packed and labelled for photographic purposes; or

       (b) in preparations packed and labelled for testing water except tablets containing 10 mg or less of diethyl‑para‑phenylenediamine or dimethyl‑para‑phenylenediamine in opaque strip packaging provided the directions for use include the statement, "Do not discard testing solutions into the pool"; or

       (c) in hair dye preparations except when the immediate container and primary pack are labelled with the following statements:

          (i) KEEP OUT OF REACH OF CHILDREN; and

          (ii) WARNING ‒ This product contains ingredients which may cause skin irritation to certain individuals. A preliminary test according to the accompanying directions should be made before use. This product must not be used for dyeing eyelashes or eyebrows; to do so may be injurious to the eye;

        written in letters not less than 1.5 mm in height; or

       (d) in eyelash and eyebrow tinting products when the immediate container and primary pack are labelled with the following statement:

           WARNING ‒ This product contains ingredients which may cause skin irritation to certain individuals, and when used for eyelash and eyebrow tinting may cause injury to the eye. A preliminary test according to the